<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00912847</url>
  </required_header>
  <id_info>
    <org_study_id>RHCC002</org_study_id>
    <nct_id>NCT00912847</nct_id>
  </id_info>
  <brief_title>Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma</brief_title>
  <official_title>Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular Carcinoma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is:

        1. To establish and compare the diagnostic utilities for hepatocellular carcinoma (HCC)
           screening tests of (a) HS-AFP, (b) AFP + US,(c) AFP alone and (d) US alone (within HBV
           carriers between age 40 and 70 years);

        2. To establish the cost-effectiveness of the screening tests;

        3. To compare tumor sizes, resection rates, and survival rates up to 18 months between
           those who were screened by HS-AFP those of a historical control group that was not
           screened.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 1997</start_date>
  <completion_date type="Actual">April 2004</completion_date>
  <primary_completion_date type="Actual">April 2004</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">1018</enrollment>
  <condition>Hepatitis B Virus</condition>
  <arm_group>
    <arm_group_label>JHC</arm_group_label>
    <description>AFP &gt; 20 ng/ml and USG positive</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non JHC</arm_group_label>
    <description>patient without AFP &gt; 20 or USG negative</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        HBV carriers between age 40 and 70 years
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 40 and 70 years

          -  Seropositive for HBsAg

          -  Child's A or B

          -  Life expectancy of more than 2 years

        Exclusion Criteria:

          -  Non-HBV related cirrhosis

          -  History of malignancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 1, 2009</study_first_submitted>
  <study_first_submitted_qc>June 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2009</study_first_posted>
  <last_update_submitted>June 1, 2009</last_update_submitted>
  <last_update_submitted_qc>June 1, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 3, 2009</last_update_posted>
  <responsible_party>
    <name_title>Prof. Tony Mok</name_title>
    <organization>Clinical Oncology</organization>
  </responsible_party>
  <keyword>HBV carriers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

